Please assess the completion status of the following clinical trial:

Trial Title: Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Normal healthy adult volunteers without known gastrointestinal disease~* Aged 18-70 years~* Able to provide written informed consent before participating in the study~* Able to communicate adequately with the investigator and to comply with the requirements for the entire study.~Exclusion Criteria:~* Known allergy to erythromycin;~* Use of drugs that have known contraindication with erythromycin (concomitant therapy with astemizole, cisapride, pimozide, or terfenadine)~* Corrected QT interval on EKG \>460 msec~* Certain medications (i.e., theophylline, digoxin, oral anti-coagulant, benzodiazepine, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors) will either be excluded from the study or, if medically safe, will be asked to discontinue the medication for 4 half-lives before beginning the study.~* Use of medications that alter GI motility e.g., narcotics, medications with significant anticholinergic effects~* Pregnant or breast-feeding females~* Known claustrophobia~* Known family history of sudden death or congenital QT prolongation~* Presence of pacemaker, internal defibrillator, or other non-MR compatible device~* Patients with known metal present within their abdomen

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Erythromycin (Type: ACTIVE_COMPARATOR): Erythromycin 200 mg i.v. suspension, Barium Sulfate Solution, and Magnetic Resonance Imaging
- Placebo (Type: PLACEBO_COMPARATOR): Matching placebo i.v. suspension, Barium Sulfate Solution, and Magnetic Resonance Imaging

Based on this trial design, predict the completion outcome and termination type (if applicable).